The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

DUBLIN--(BUSINESS WIRE)--The "Data Integrity and Document Management Training Course" conference has been added to ResearchAndMarkets.com's offering. Document management and data integrity are a key ...

Market opportunities arise from the growing need for modernization and compliance assurance in FDA-regulated industries focusing on data integrity. Emphasizing cloud computing, automation, and mobile ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

Disruptions, whether positive, like the addition of new data sources, or challenging, such as supplier exits, are part of the natural evolution of open claims. Specific changes, such as expanded ...

CPHI Frankfurt 2025 highlighted a pharmaceutical industry in flux, navigating the rapid acceleration of artificial ...

BioXcel Therapeutics faces regulatory challenges after the FDA found inconsistencies in one of its clinical trial sites, jeopardizing the supplementary approval of its drug, IGALMI. BioXcel's ...

The US Food and Drug Administration (FDA) released a draft guidance on April 3 providing recommendations to sponsors and testing sites on data integrity for bioavailability and bioequivalence (BA/BE) ...

Market opportunities lie in modernizing software development and validation approaches, emphasizing agility and continuous validation to meet changing needs, while ensuring compliance with FDA ...

Healthcare professionals don’t trust your digital content. That is the stark conclusion of a survey of HCPs, which found 80% of consultants are skeptical of pharma content because of doubts about the ...

In the age of advanced data analytics and artificial intelligence (AI), organizations are continuously confronted with new and increasingly complex challenges of data legitimacy. The proliferation of ...